Hong Kong stock fluctuation | Foundation Medicine-B (02616.HK) rises more than 8% in the afternoon. Two drugs are planned to start new drug clinical trial application preparation work in the second half of the year.

According to the Zhixin Financial APP, China Aoxing Pharmaceutical-B (02616.HK) rose more than 8% in the afternoon, as of the time of publication, it increased by 8.28% to HK$4.97, with a turnover of HKD 57,186.2 million.